Chemical & Material
Global Bisabolene Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 04, 25
- ID: 569308
- Pages: 143
- Figures: 144
- Views: 1
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Bisabolene market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
BASF
Givaudan
Augustus Oils
Misri Fumet
Triveni Chemicals
Aurochemicals
Hesheng Tech
Hairui Chemical
Segment by Type
α-Bisabolene
β-Bisabolene
γ-Bisabolene
Segment by Application
Food
Cosmetic
Pharmaceutical
Others
Production by Region
North America
Europe
China
Japan
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Bisabolene study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Bisabolene market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
BASF
Givaudan
Augustus Oils
Misri Fumet
Triveni Chemicals
Aurochemicals
Hesheng Tech
Hairui Chemical
Segment by Type
α-Bisabolene
β-Bisabolene
γ-Bisabolene
Segment by Application
Food
Cosmetic
Pharmaceutical
Others
Production by Region
North America
Europe
China
Japan
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Bisabolene study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Bisabolene: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Bisabolene Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 α-Bisabolene
1.2.3 β-Bisabolene
1.2.4 γ-Bisabolene
1.3 Market Segmentation by Application
1.3.1 Global Bisabolene Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Food
1.3.3 Cosmetic
1.3.4 Pharmaceutical
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bisabolene Revenue Estimates and Forecasts 2020-2031
2.2 Global Bisabolene Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Bisabolene Sales Estimates and Forecasts 2020-2031
2.4 Global Bisabolene Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Bisabolene Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Bisabolene Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Bisabolene Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 α-Bisabolene Market Size by Manufacturers
4.5.2 β-Bisabolene Market Size by Manufacturers
4.5.3 γ-Bisabolene Market Size by Manufacturers
4.6 Global Bisabolene Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Bisabolene Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Bisabolene Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Bisabolene Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Bisabolene Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Bisabolene Sales and Revenue by Type (2020-2031)
7.4 North America Bisabolene Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Bisabolene Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Bisabolene Sales and Revenue by Type (2020-2031)
8.4 Europe Bisabolene Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Bisabolene Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Bisabolene Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Bisabolene Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Bisabolene Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Bisabolene Sales and Revenue by Type (2020-2031)
10.4 Central and South America Bisabolene Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Bisabolene Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Bisabolene Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Bisabolene Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Bisabolene Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 BASF
12.1.1 BASF Corporation Information
12.1.2 BASF Business Overview
12.1.3 BASF Bisabolene Product Models, Descriptions and Specifications
12.1.4 BASF Bisabolene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 BASF Bisabolene Sales by Product in 2024
12.1.6 BASF Bisabolene Sales by Application in 2024
12.1.7 BASF Bisabolene Sales by Geographic Area in 2024
12.1.8 BASF Bisabolene SWOT Analysis
12.1.9 BASF Recent Developments
12.2 Givaudan
12.2.1 Givaudan Corporation Information
12.2.2 Givaudan Business Overview
12.2.3 Givaudan Bisabolene Product Models, Descriptions and Specifications
12.2.4 Givaudan Bisabolene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Givaudan Bisabolene Sales by Product in 2024
12.2.6 Givaudan Bisabolene Sales by Application in 2024
12.2.7 Givaudan Bisabolene Sales by Geographic Area in 2024
12.2.8 Givaudan Bisabolene SWOT Analysis
12.2.9 Givaudan Recent Developments
12.3 Augustus Oils
12.3.1 Augustus Oils Corporation Information
12.3.2 Augustus Oils Business Overview
12.3.3 Augustus Oils Bisabolene Product Models, Descriptions and Specifications
12.3.4 Augustus Oils Bisabolene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Augustus Oils Bisabolene Sales by Product in 2024
12.3.6 Augustus Oils Bisabolene Sales by Application in 2024
12.3.7 Augustus Oils Bisabolene Sales by Geographic Area in 2024
12.3.8 Augustus Oils Bisabolene SWOT Analysis
12.3.9 Augustus Oils Recent Developments
12.4 Misri Fumet
12.4.1 Misri Fumet Corporation Information
12.4.2 Misri Fumet Business Overview
12.4.3 Misri Fumet Bisabolene Product Models, Descriptions and Specifications
12.4.4 Misri Fumet Bisabolene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Misri Fumet Bisabolene Sales by Product in 2024
12.4.6 Misri Fumet Bisabolene Sales by Application in 2024
12.4.7 Misri Fumet Bisabolene Sales by Geographic Area in 2024
12.4.8 Misri Fumet Bisabolene SWOT Analysis
12.4.9 Misri Fumet Recent Developments
12.5 Triveni Chemicals
12.5.1 Triveni Chemicals Corporation Information
12.5.2 Triveni Chemicals Business Overview
12.5.3 Triveni Chemicals Bisabolene Product Models, Descriptions and Specifications
12.5.4 Triveni Chemicals Bisabolene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Triveni Chemicals Bisabolene Sales by Product in 2024
12.5.6 Triveni Chemicals Bisabolene Sales by Application in 2024
12.5.7 Triveni Chemicals Bisabolene Sales by Geographic Area in 2024
12.5.8 Triveni Chemicals Bisabolene SWOT Analysis
12.5.9 Triveni Chemicals Recent Developments
12.6 Aurochemicals
12.6.1 Aurochemicals Corporation Information
12.6.2 Aurochemicals Business Overview
12.6.3 Aurochemicals Bisabolene Product Models, Descriptions and Specifications
12.6.4 Aurochemicals Bisabolene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Aurochemicals Recent Developments
12.7 Hesheng Tech
12.7.1 Hesheng Tech Corporation Information
12.7.2 Hesheng Tech Business Overview
12.7.3 Hesheng Tech Bisabolene Product Models, Descriptions and Specifications
12.7.4 Hesheng Tech Bisabolene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Hesheng Tech Recent Developments
12.8 Hairui Chemical
12.8.1 Hairui Chemical Corporation Information
12.8.2 Hairui Chemical Business Overview
12.8.3 Hairui Chemical Bisabolene Product Models, Descriptions and Specifications
12.8.4 Hairui Chemical Bisabolene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Hairui Chemical Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Bisabolene Industry Chain
13.2 Bisabolene Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Bisabolene Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Bisabolene Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Bisabolene Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Bisabolene Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
1.1 Introduction to Bisabolene: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Bisabolene Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 α-Bisabolene
1.2.3 β-Bisabolene
1.2.4 γ-Bisabolene
1.3 Market Segmentation by Application
1.3.1 Global Bisabolene Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Food
1.3.3 Cosmetic
1.3.4 Pharmaceutical
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bisabolene Revenue Estimates and Forecasts 2020-2031
2.2 Global Bisabolene Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Bisabolene Sales Estimates and Forecasts 2020-2031
2.4 Global Bisabolene Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Bisabolene Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Bisabolene Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Bisabolene Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 α-Bisabolene Market Size by Manufacturers
4.5.2 β-Bisabolene Market Size by Manufacturers
4.5.3 γ-Bisabolene Market Size by Manufacturers
4.6 Global Bisabolene Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Bisabolene Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Bisabolene Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Bisabolene Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Bisabolene Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Bisabolene Sales and Revenue by Type (2020-2031)
7.4 North America Bisabolene Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Bisabolene Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Bisabolene Sales and Revenue by Type (2020-2031)
8.4 Europe Bisabolene Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Bisabolene Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Bisabolene Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Bisabolene Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Bisabolene Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Bisabolene Sales and Revenue by Type (2020-2031)
10.4 Central and South America Bisabolene Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Bisabolene Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Bisabolene Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Bisabolene Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Bisabolene Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 BASF
12.1.1 BASF Corporation Information
12.1.2 BASF Business Overview
12.1.3 BASF Bisabolene Product Models, Descriptions and Specifications
12.1.4 BASF Bisabolene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 BASF Bisabolene Sales by Product in 2024
12.1.6 BASF Bisabolene Sales by Application in 2024
12.1.7 BASF Bisabolene Sales by Geographic Area in 2024
12.1.8 BASF Bisabolene SWOT Analysis
12.1.9 BASF Recent Developments
12.2 Givaudan
12.2.1 Givaudan Corporation Information
12.2.2 Givaudan Business Overview
12.2.3 Givaudan Bisabolene Product Models, Descriptions and Specifications
12.2.4 Givaudan Bisabolene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Givaudan Bisabolene Sales by Product in 2024
12.2.6 Givaudan Bisabolene Sales by Application in 2024
12.2.7 Givaudan Bisabolene Sales by Geographic Area in 2024
12.2.8 Givaudan Bisabolene SWOT Analysis
12.2.9 Givaudan Recent Developments
12.3 Augustus Oils
12.3.1 Augustus Oils Corporation Information
12.3.2 Augustus Oils Business Overview
12.3.3 Augustus Oils Bisabolene Product Models, Descriptions and Specifications
12.3.4 Augustus Oils Bisabolene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Augustus Oils Bisabolene Sales by Product in 2024
12.3.6 Augustus Oils Bisabolene Sales by Application in 2024
12.3.7 Augustus Oils Bisabolene Sales by Geographic Area in 2024
12.3.8 Augustus Oils Bisabolene SWOT Analysis
12.3.9 Augustus Oils Recent Developments
12.4 Misri Fumet
12.4.1 Misri Fumet Corporation Information
12.4.2 Misri Fumet Business Overview
12.4.3 Misri Fumet Bisabolene Product Models, Descriptions and Specifications
12.4.4 Misri Fumet Bisabolene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Misri Fumet Bisabolene Sales by Product in 2024
12.4.6 Misri Fumet Bisabolene Sales by Application in 2024
12.4.7 Misri Fumet Bisabolene Sales by Geographic Area in 2024
12.4.8 Misri Fumet Bisabolene SWOT Analysis
12.4.9 Misri Fumet Recent Developments
12.5 Triveni Chemicals
12.5.1 Triveni Chemicals Corporation Information
12.5.2 Triveni Chemicals Business Overview
12.5.3 Triveni Chemicals Bisabolene Product Models, Descriptions and Specifications
12.5.4 Triveni Chemicals Bisabolene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Triveni Chemicals Bisabolene Sales by Product in 2024
12.5.6 Triveni Chemicals Bisabolene Sales by Application in 2024
12.5.7 Triveni Chemicals Bisabolene Sales by Geographic Area in 2024
12.5.8 Triveni Chemicals Bisabolene SWOT Analysis
12.5.9 Triveni Chemicals Recent Developments
12.6 Aurochemicals
12.6.1 Aurochemicals Corporation Information
12.6.2 Aurochemicals Business Overview
12.6.3 Aurochemicals Bisabolene Product Models, Descriptions and Specifications
12.6.4 Aurochemicals Bisabolene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Aurochemicals Recent Developments
12.7 Hesheng Tech
12.7.1 Hesheng Tech Corporation Information
12.7.2 Hesheng Tech Business Overview
12.7.3 Hesheng Tech Bisabolene Product Models, Descriptions and Specifications
12.7.4 Hesheng Tech Bisabolene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Hesheng Tech Recent Developments
12.8 Hairui Chemical
12.8.1 Hairui Chemical Corporation Information
12.8.2 Hairui Chemical Business Overview
12.8.3 Hairui Chemical Bisabolene Product Models, Descriptions and Specifications
12.8.4 Hairui Chemical Bisabolene Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Hairui Chemical Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Bisabolene Industry Chain
13.2 Bisabolene Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Bisabolene Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Bisabolene Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Bisabolene Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Bisabolene Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
List of Tables
Table 1. Global Bisabolene Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Bisabolene Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Bisabolene Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Bisabolene Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Bisabolene Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Bisabolene Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Bisabolene Sales by Region (2020-2025) & (Tons)
Table 8. Global Bisabolene Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Bisabolene Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Bisabolene Production by Region (2020-2025) & (Tons)
Table 12. Global Bisabolene Production by Region (2026-2031) & (Tons)
Table 13. Global Bisabolene Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Bisabolene Sales Share by Manufacturers (2020-2025)
Table 15. Global Bisabolene Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Bisabolene Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Bisabolene by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bisabolene as of 2024)
Table 19. Global Bisabolene Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Bisabolene Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Bisabolene Manufacturing Base and Headquarters
Table 22. Global Bisabolene Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Bisabolene Sales by Type (2020-2025) & (Tons)
Table 26. Global Bisabolene Sales by Type (2026-2031) & (Tons)
Table 27. Global Bisabolene Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Bisabolene Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Bisabolene ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Bisabolene Sales by Application (2020-2025) & (Tons)
Table 32. Global Bisabolene Sales by Application (2026-2031) & (Tons)
Table 33. Bisabolene High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Bisabolene Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Bisabolene Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Bisabolene ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Bisabolene Growth Accelerators and Market Barriers
Table 40. North America Bisabolene Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Bisabolene Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Bisabolene Growth Accelerators and Market Barriers
Table 43. Europe Bisabolene Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Bisabolene Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Bisabolene Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Bisabolene Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Bisabolene Growth Accelerators and Market Barriers
Table 48. Southeast Asia Bisabolene Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Bisabolene Investment Opportunities and Key Challenges
Table 50. Central and South America Bisabolene Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Bisabolene Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Bisabolene Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. BASF Corporation Information
Table 54. BASF Description and Major Businesses
Table 55. BASF Product Models, Descriptions and Specifications
Table 56. BASF Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. BASF Sales Value Proportion by Product in 2024
Table 58. BASF Sales Value Proportion by Application in 2024
Table 59. BASF Sales Value Proportion by Geographic Area in 2024
Table 60. BASF Bisabolene SWOT Analysis
Table 61. BASF Recent Developments
Table 62. Givaudan Corporation Information
Table 63. Givaudan Description and Major Businesses
Table 64. Givaudan Product Models, Descriptions and Specifications
Table 65. Givaudan Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Givaudan Sales Value Proportion by Product in 2024
Table 67. Givaudan Sales Value Proportion by Application in 2024
Table 68. Givaudan Sales Value Proportion by Geographic Area in 2024
Table 69. Givaudan Bisabolene SWOT Analysis
Table 70. Givaudan Recent Developments
Table 71. Augustus Oils Corporation Information
Table 72. Augustus Oils Description and Major Businesses
Table 73. Augustus Oils Product Models, Descriptions and Specifications
Table 74. Augustus Oils Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Augustus Oils Sales Value Proportion by Product in 2024
Table 76. Augustus Oils Sales Value Proportion by Application in 2024
Table 77. Augustus Oils Sales Value Proportion by Geographic Area in 2024
Table 78. Augustus Oils Bisabolene SWOT Analysis
Table 79. Augustus Oils Recent Developments
Table 80. Misri Fumet Corporation Information
Table 81. Misri Fumet Description and Major Businesses
Table 82. Misri Fumet Product Models, Descriptions and Specifications
Table 83. Misri Fumet Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Misri Fumet Sales Value Proportion by Product in 2024
Table 85. Misri Fumet Sales Value Proportion by Application in 2024
Table 86. Misri Fumet Sales Value Proportion by Geographic Area in 2024
Table 87. Misri Fumet Bisabolene SWOT Analysis
Table 88. Misri Fumet Recent Developments
Table 89. Triveni Chemicals Corporation Information
Table 90. Triveni Chemicals Description and Major Businesses
Table 91. Triveni Chemicals Product Models, Descriptions and Specifications
Table 92. Triveni Chemicals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Triveni Chemicals Sales Value Proportion by Product in 2024
Table 94. Triveni Chemicals Sales Value Proportion by Application in 2024
Table 95. Triveni Chemicals Sales Value Proportion by Geographic Area in 2024
Table 96. Triveni Chemicals Bisabolene SWOT Analysis
Table 97. Triveni Chemicals Recent Developments
Table 98. Aurochemicals Corporation Information
Table 99. Aurochemicals Description and Major Businesses
Table 100. Aurochemicals Product Models, Descriptions and Specifications
Table 101. Aurochemicals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Aurochemicals Recent Developments
Table 103. Hesheng Tech Corporation Information
Table 104. Hesheng Tech Description and Major Businesses
Table 105. Hesheng Tech Product Models, Descriptions and Specifications
Table 106. Hesheng Tech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. Hesheng Tech Recent Developments
Table 108. Hairui Chemical Corporation Information
Table 109. Hairui Chemical Description and Major Businesses
Table 110. Hairui Chemical Product Models, Descriptions and Specifications
Table 111. Hairui Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. Hairui Chemical Recent Developments
Table 113. Key Raw Materials Distribution
Table 114. Raw Materials Key Suppliers
Table 115. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 116. Milestones in Production Technology Evolution
Table 117. Distributors List
Table 118. Market Trends and Market Evolution
Table 119. Market Drivers and Opportunities
Table 120. Market Challenges, Risks, and Restraints
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Bisabolene Product Picture
Figure 2. Global Bisabolene Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. α-Bisabolene Product Picture
Figure 4. β-Bisabolene Product Picture
Figure 5. γ-Bisabolene Product Picture
Figure 6. Global Bisabolene Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Food
Figure 8. Cosmetic
Figure 9. Pharmaceutical
Figure 10. Others
Figure 11. Bisabolene Report Years Considered
Figure 12. Global Bisabolene Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 14. Global Bisabolene Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Bisabolene Revenue Market Share by Region (2020-2031)
Figure 16. Global Bisabolene Sales (2020-2031) & (Tons)
Figure 17. Global Bisabolene Sales (CAGR) by Region (2020-2031) (Tons)
Figure 18. Global Bisabolene Sales Market Share by Region (2020-2031)
Figure 19. Global Bisabolene Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 20. Global Bisabolene Production Trend by Region (2020-2031) (Tons)
Figure 21. Global Bisabolene Production Market Share by Region (2020-2031)
Figure 22. Production Capacity Enablers & Constraints
Figure 23. Bisabolene Production Growth Rate in North America (2020-2031) & (Tons)
Figure 24. Bisabolene Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 25. Bisabolene Production Growth Rate in China (2020-2031) & (Tons)
Figure 26. Bisabolene Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 27. Top 5 and Top 10 Manufacturers Bisabolene Sales Volume Market Share in 2024
Figure 28. Global Bisabolene Revenue Market Share Ranking (2024)
Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 30. α-Bisabolene Revenue Market Share by Manufacturer in 2024
Figure 31. β-Bisabolene Revenue Market Share by Manufacturer in 2024
Figure 32. γ-Bisabolene Revenue Market Share by Manufacturer in 2024
Figure 33. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 34. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 35. Global Bisabolene Sales Market Share by Type (2020-2031)
Figure 36. Global Bisabolene Revenue Market Share by Type (2020-2031)
Figure 37. Global Bisabolene Sales Market Share by Application (2020-2031)
Figure 38. Global Bisabolene Revenue Market Share by Application (2020-2031)
Figure 39. North America Bisabolene Sales YoY (2020-2031) & (Tons)
Figure 40. North America Bisabolene Revenue YoY (2020-2031) & (US$ Million)
Figure 41. North America Top 5 Manufacturers Bisabolene Sales Revenue (US$ Million) in 2024
Figure 42. North America Bisabolene Sales Volume (Tons) by Type (2020- 2031)
Figure 43. North America Bisabolene Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 44. North America Bisabolene Sales Volume (Tons) by Application (2020-2031)
Figure 45. North America Bisabolene Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. US Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 47. Canada Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 48. Mexico Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 49. Europe Bisabolene Sales YoY (2020-2031) & (Tons)
Figure 50. Europe Bisabolene Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Europe Top 5 Manufacturers Bisabolene Sales Revenue (US$ Million) in 2024
Figure 52. Europe Bisabolene Sales Volume (Tons) by Type (2020-2031)
Figure 53. Europe Bisabolene Sales Revenue (US$ Million) by Type (2020-2031)
Figure 54. Europe Bisabolene Sales Volume (Tons) by Application (2020-2031)
Figure 55. Europe Bisabolene Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Germany Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 57. France Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 58. U.K. Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 59. Italy Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 60. Russia Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 61. Asia-Pacific Bisabolene Sales YoY (2020-2031) & (Tons)
Figure 62. Asia-Pacific Bisabolene Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Asia-Pacific Top 8 Manufacturers Bisabolene Sales Revenue (US$ Million) in 2024
Figure 64. Asia-Pacific Bisabolene Sales Volume (Tons) by Type (2020- 2031)
Figure 65. Asia-Pacific Bisabolene Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 66. Asia-Pacific Bisabolene Sales Volume (Tons) by Application (2020-2031)
Figure 67. Asia-Pacific Bisabolene Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Indonesia Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 69. Japan Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 70. South Korea Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 71. China Taiwan Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 72. India Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 73. Central and South America Bisabolene Sales YoY (2020-2031) & (Tons)
Figure 74. Central and South America Bisabolene Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Central and South America Top 5 Manufacturers Bisabolene Sales Revenue (US$ Million) in 2024
Figure 76. Central and South America Bisabolene Sales Volume (Tons) by Type (2021-2031)
Figure 77. Central and South America Bisabolene Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Central and South America Bisabolene Sales Volume (Tons) by Application (2020-2031)
Figure 79. Central and South America Bisabolene Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. Brazil Bisabolene Revenue (2020-2025) & (US$ Million)
Figure 81. Argentina Bisabolene Revenue (2020-2025) & (US$ Million)
Figure 82. Middle East, and Africa Bisabolene Sales YoY (2020-2031) & (Tons)
Figure 83. Middle East and Africa Bisabolene Revenue YoY (2020-2031) & (US$ Million)
Figure 84. Middle East and Africa Top 5 Manufacturers Bisabolene Sales Revenue (US$ Million) in 2024
Figure 85. Middle East and Africa Bisabolene Sales Volume (Tons) by Type (2021-2031)
Figure 86. South America Bisabolene Sales Revenue (US$ Million) by Type (2020-2031)
Figure 87. Middle East and Africa Bisabolene Sales Volume (Tons) by Application (2020-2031)
Figure 88. Middle East and Africa Bisabolene Sales Revenue (US$ Million) by Application (2020-2031)
Figure 89. GCC Countries Bisabolene Revenue (2020-2025) & (US$ Million)
Figure 90. Turkey Bisabolene Revenue (2020-2025) & (US$ Million)
Figure 91. Egypt Bisabolene Revenue (2020-2025) & (US$ Million)
Figure 92. South Africa Bisabolene Revenue (2020-2025) & (US$ Million)
Figure 93. Bisabolene Industry Chain Mapping
Figure 94. Regional Bisabolene Manufacturing Base Distribution (%)
Figure 95. Bisabolene Production Process
Figure 96. Regional Bisabolene Production Cost Structure
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed
Table 1. Global Bisabolene Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Bisabolene Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Bisabolene Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Bisabolene Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Bisabolene Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Bisabolene Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Bisabolene Sales by Region (2020-2025) & (Tons)
Table 8. Global Bisabolene Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Bisabolene Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Bisabolene Production by Region (2020-2025) & (Tons)
Table 12. Global Bisabolene Production by Region (2026-2031) & (Tons)
Table 13. Global Bisabolene Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Bisabolene Sales Share by Manufacturers (2020-2025)
Table 15. Global Bisabolene Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Bisabolene Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Bisabolene by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bisabolene as of 2024)
Table 19. Global Bisabolene Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Bisabolene Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Bisabolene Manufacturing Base and Headquarters
Table 22. Global Bisabolene Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Bisabolene Sales by Type (2020-2025) & (Tons)
Table 26. Global Bisabolene Sales by Type (2026-2031) & (Tons)
Table 27. Global Bisabolene Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Bisabolene Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Bisabolene ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Bisabolene Sales by Application (2020-2025) & (Tons)
Table 32. Global Bisabolene Sales by Application (2026-2031) & (Tons)
Table 33. Bisabolene High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Bisabolene Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Bisabolene Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Bisabolene ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Bisabolene Growth Accelerators and Market Barriers
Table 40. North America Bisabolene Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Bisabolene Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Bisabolene Growth Accelerators and Market Barriers
Table 43. Europe Bisabolene Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Bisabolene Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Bisabolene Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Bisabolene Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Bisabolene Growth Accelerators and Market Barriers
Table 48. Southeast Asia Bisabolene Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Bisabolene Investment Opportunities and Key Challenges
Table 50. Central and South America Bisabolene Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Bisabolene Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Bisabolene Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. BASF Corporation Information
Table 54. BASF Description and Major Businesses
Table 55. BASF Product Models, Descriptions and Specifications
Table 56. BASF Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. BASF Sales Value Proportion by Product in 2024
Table 58. BASF Sales Value Proportion by Application in 2024
Table 59. BASF Sales Value Proportion by Geographic Area in 2024
Table 60. BASF Bisabolene SWOT Analysis
Table 61. BASF Recent Developments
Table 62. Givaudan Corporation Information
Table 63. Givaudan Description and Major Businesses
Table 64. Givaudan Product Models, Descriptions and Specifications
Table 65. Givaudan Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Givaudan Sales Value Proportion by Product in 2024
Table 67. Givaudan Sales Value Proportion by Application in 2024
Table 68. Givaudan Sales Value Proportion by Geographic Area in 2024
Table 69. Givaudan Bisabolene SWOT Analysis
Table 70. Givaudan Recent Developments
Table 71. Augustus Oils Corporation Information
Table 72. Augustus Oils Description and Major Businesses
Table 73. Augustus Oils Product Models, Descriptions and Specifications
Table 74. Augustus Oils Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Augustus Oils Sales Value Proportion by Product in 2024
Table 76. Augustus Oils Sales Value Proportion by Application in 2024
Table 77. Augustus Oils Sales Value Proportion by Geographic Area in 2024
Table 78. Augustus Oils Bisabolene SWOT Analysis
Table 79. Augustus Oils Recent Developments
Table 80. Misri Fumet Corporation Information
Table 81. Misri Fumet Description and Major Businesses
Table 82. Misri Fumet Product Models, Descriptions and Specifications
Table 83. Misri Fumet Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Misri Fumet Sales Value Proportion by Product in 2024
Table 85. Misri Fumet Sales Value Proportion by Application in 2024
Table 86. Misri Fumet Sales Value Proportion by Geographic Area in 2024
Table 87. Misri Fumet Bisabolene SWOT Analysis
Table 88. Misri Fumet Recent Developments
Table 89. Triveni Chemicals Corporation Information
Table 90. Triveni Chemicals Description and Major Businesses
Table 91. Triveni Chemicals Product Models, Descriptions and Specifications
Table 92. Triveni Chemicals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Triveni Chemicals Sales Value Proportion by Product in 2024
Table 94. Triveni Chemicals Sales Value Proportion by Application in 2024
Table 95. Triveni Chemicals Sales Value Proportion by Geographic Area in 2024
Table 96. Triveni Chemicals Bisabolene SWOT Analysis
Table 97. Triveni Chemicals Recent Developments
Table 98. Aurochemicals Corporation Information
Table 99. Aurochemicals Description and Major Businesses
Table 100. Aurochemicals Product Models, Descriptions and Specifications
Table 101. Aurochemicals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Aurochemicals Recent Developments
Table 103. Hesheng Tech Corporation Information
Table 104. Hesheng Tech Description and Major Businesses
Table 105. Hesheng Tech Product Models, Descriptions and Specifications
Table 106. Hesheng Tech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. Hesheng Tech Recent Developments
Table 108. Hairui Chemical Corporation Information
Table 109. Hairui Chemical Description and Major Businesses
Table 110. Hairui Chemical Product Models, Descriptions and Specifications
Table 111. Hairui Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. Hairui Chemical Recent Developments
Table 113. Key Raw Materials Distribution
Table 114. Raw Materials Key Suppliers
Table 115. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 116. Milestones in Production Technology Evolution
Table 117. Distributors List
Table 118. Market Trends and Market Evolution
Table 119. Market Drivers and Opportunities
Table 120. Market Challenges, Risks, and Restraints
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Bisabolene Product Picture
Figure 2. Global Bisabolene Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. α-Bisabolene Product Picture
Figure 4. β-Bisabolene Product Picture
Figure 5. γ-Bisabolene Product Picture
Figure 6. Global Bisabolene Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Food
Figure 8. Cosmetic
Figure 9. Pharmaceutical
Figure 10. Others
Figure 11. Bisabolene Report Years Considered
Figure 12. Global Bisabolene Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 14. Global Bisabolene Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Bisabolene Revenue Market Share by Region (2020-2031)
Figure 16. Global Bisabolene Sales (2020-2031) & (Tons)
Figure 17. Global Bisabolene Sales (CAGR) by Region (2020-2031) (Tons)
Figure 18. Global Bisabolene Sales Market Share by Region (2020-2031)
Figure 19. Global Bisabolene Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 20. Global Bisabolene Production Trend by Region (2020-2031) (Tons)
Figure 21. Global Bisabolene Production Market Share by Region (2020-2031)
Figure 22. Production Capacity Enablers & Constraints
Figure 23. Bisabolene Production Growth Rate in North America (2020-2031) & (Tons)
Figure 24. Bisabolene Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 25. Bisabolene Production Growth Rate in China (2020-2031) & (Tons)
Figure 26. Bisabolene Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 27. Top 5 and Top 10 Manufacturers Bisabolene Sales Volume Market Share in 2024
Figure 28. Global Bisabolene Revenue Market Share Ranking (2024)
Figure 29. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 30. α-Bisabolene Revenue Market Share by Manufacturer in 2024
Figure 31. β-Bisabolene Revenue Market Share by Manufacturer in 2024
Figure 32. γ-Bisabolene Revenue Market Share by Manufacturer in 2024
Figure 33. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 34. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 35. Global Bisabolene Sales Market Share by Type (2020-2031)
Figure 36. Global Bisabolene Revenue Market Share by Type (2020-2031)
Figure 37. Global Bisabolene Sales Market Share by Application (2020-2031)
Figure 38. Global Bisabolene Revenue Market Share by Application (2020-2031)
Figure 39. North America Bisabolene Sales YoY (2020-2031) & (Tons)
Figure 40. North America Bisabolene Revenue YoY (2020-2031) & (US$ Million)
Figure 41. North America Top 5 Manufacturers Bisabolene Sales Revenue (US$ Million) in 2024
Figure 42. North America Bisabolene Sales Volume (Tons) by Type (2020- 2031)
Figure 43. North America Bisabolene Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 44. North America Bisabolene Sales Volume (Tons) by Application (2020-2031)
Figure 45. North America Bisabolene Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. US Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 47. Canada Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 48. Mexico Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 49. Europe Bisabolene Sales YoY (2020-2031) & (Tons)
Figure 50. Europe Bisabolene Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Europe Top 5 Manufacturers Bisabolene Sales Revenue (US$ Million) in 2024
Figure 52. Europe Bisabolene Sales Volume (Tons) by Type (2020-2031)
Figure 53. Europe Bisabolene Sales Revenue (US$ Million) by Type (2020-2031)
Figure 54. Europe Bisabolene Sales Volume (Tons) by Application (2020-2031)
Figure 55. Europe Bisabolene Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Germany Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 57. France Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 58. U.K. Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 59. Italy Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 60. Russia Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 61. Asia-Pacific Bisabolene Sales YoY (2020-2031) & (Tons)
Figure 62. Asia-Pacific Bisabolene Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Asia-Pacific Top 8 Manufacturers Bisabolene Sales Revenue (US$ Million) in 2024
Figure 64. Asia-Pacific Bisabolene Sales Volume (Tons) by Type (2020- 2031)
Figure 65. Asia-Pacific Bisabolene Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 66. Asia-Pacific Bisabolene Sales Volume (Tons) by Application (2020-2031)
Figure 67. Asia-Pacific Bisabolene Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Indonesia Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 69. Japan Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 70. South Korea Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 71. China Taiwan Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 72. India Bisabolene Revenue (2020-2031) & (US$ Million)
Figure 73. Central and South America Bisabolene Sales YoY (2020-2031) & (Tons)
Figure 74. Central and South America Bisabolene Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Central and South America Top 5 Manufacturers Bisabolene Sales Revenue (US$ Million) in 2024
Figure 76. Central and South America Bisabolene Sales Volume (Tons) by Type (2021-2031)
Figure 77. Central and South America Bisabolene Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Central and South America Bisabolene Sales Volume (Tons) by Application (2020-2031)
Figure 79. Central and South America Bisabolene Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. Brazil Bisabolene Revenue (2020-2025) & (US$ Million)
Figure 81. Argentina Bisabolene Revenue (2020-2025) & (US$ Million)
Figure 82. Middle East, and Africa Bisabolene Sales YoY (2020-2031) & (Tons)
Figure 83. Middle East and Africa Bisabolene Revenue YoY (2020-2031) & (US$ Million)
Figure 84. Middle East and Africa Top 5 Manufacturers Bisabolene Sales Revenue (US$ Million) in 2024
Figure 85. Middle East and Africa Bisabolene Sales Volume (Tons) by Type (2021-2031)
Figure 86. South America Bisabolene Sales Revenue (US$ Million) by Type (2020-2031)
Figure 87. Middle East and Africa Bisabolene Sales Volume (Tons) by Application (2020-2031)
Figure 88. Middle East and Africa Bisabolene Sales Revenue (US$ Million) by Application (2020-2031)
Figure 89. GCC Countries Bisabolene Revenue (2020-2025) & (US$ Million)
Figure 90. Turkey Bisabolene Revenue (2020-2025) & (US$ Million)
Figure 91. Egypt Bisabolene Revenue (2020-2025) & (US$ Million)
Figure 92. South Africa Bisabolene Revenue (2020-2025) & (US$ Million)
Figure 93. Bisabolene Industry Chain Mapping
Figure 94. Regional Bisabolene Manufacturing Base Distribution (%)
Figure 95. Bisabolene Production Process
Figure 96. Regional Bisabolene Production Cost Structure
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232